Blog
Articles, guides, and regulatory updates from our community.
AllClinical ApplicationsLongevityPeptide BasicsProvider ResourcesResearch & ScienceSafety & RegulationWeight Management
503A503BAnti-AgingBPC-157BremelanotideCJC-1295CircadianComplianceCompoundingCopper PeptideDSIPEpitalonEvidence ReviewFDAFDA ApprovedGHK-CuGIGLP-1Getting StartedGrowth HormoneGut HealthHealingHumaninIBSImmune SupportImmunologyIpamorelinKPVLarazotideLongevityMOTS-cMelanocortinMitochondriaNAD+ObesityPT-141Patient EducationPeptide BasicsPharmacyProvider GuideQualityRecoveryRegulationResearchSafetySemaglutideSexual HealthSide EffectsSkin HealthSleepTesamorelinThymosin Alpha-1TirzepatideWeight Management
Showing 2 articles tagged 503BClear filters
Feb 25, 202610 min read
Safety & Regulation
FDA Peptide Regulation in 2026: What Providers Need to Know
The regulatory landscape for compounded peptides has shifted dramatically. Here's what clinicians must understand about FDA enforcement, 503A/503B rules, and the bulk drug substance list.
FDARegulationCompounding+3
By Peptide Association Editorial Team
Feb 15, 202610 min read
Provider Resources
Compounding Pharmacies and Peptide Quality: A Provider Guide
How to evaluate compounding pharmacies, understand USP standards, interpret certificates of analysis, and ensure your patients receive safe, accurately dosed peptide products.
CompoundingQuality503A+3
By Peptide Association Editorial Team